Efficacy of crizotinib in children with relapsed/refractory ALK-driven tumors including anaplastic large cell lymphoma and neuroblastoma: A Children's Oncology Group phase I consortium study.
Yael P. Mosse
Research Funding - Pfizer
Frank M. Balis
No relevant relationships to disclose
Megan S Lim
No relevant relationships to disclose
Julie Laliberte
No relevant relationships to disclose
Stephan D Voss
No relevant relationships to disclose
Elizabeth Fox
No relevant relationships to disclose
Rochelle Bagatell
No relevant relationships to disclose
Brenda Weigel
No relevant relationships to disclose
Peter C. Adamson
No relevant relationships to disclose
Ashish M Ingle
No relevant relationships to disclose
Charlotte H Ahern
No relevant relationships to disclose
Susan Blaney
No relevant relationships to disclose